Cyclerion Therapeutics, Inc. (CYCN) NASDAQ
3.02
-0.06(-1.95%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.1M |
| Enterprise Value | 855,750 |
| P/E Ratio | -2.41 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 6.56 |
| Price/Book Ratio | 1.87 |
| Enterprise/Revenue | 5.15 |
| Enterprise/EBITDA | -1.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -2.65 |
| Operating Margin | -3.37 |
Management Effectiveness
| Return On Assets | -0.62 |
| Return On Equity | -0.62 |
Income Statement
| Revenue | 2.07M |
| Revenue/Share | 0.47 |
| Gross Profit | 2.07M |
| EBITDA | -4.97M |
| Net Income | -3.53M |
| Diluted EPS | -1.09 |
Balance Sheet
| Total Cash | 2.82M |
| Total Cash/Share | 0.67 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.8 |
| Book Value Per Share | 1.61 |
Price History
| 52-Week Change | 2.03 |
| 52-Week High | 8.48 |
| 52-Week Low | 1.03 |
| Moving Average 50 Days | 3.01 |
| Moving Average 200 Days | 2.11 |
Statistics
| Average Volume | 4.58M |
| Shares Outstanding | 4.33M |
| % Held by Institutions | 5.02 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | May 16, 2023 |
